KLASSE-II-TYP-II-CRISPR-SYSTEME

Patent europeic · EP4127156 · En vigur

Inscripziun en il register

Numer da publicaziun: EP4127156
Numer da la dumonda: EP21779798
Gener: Patent europeic cun effect per la Svizra ed il Liechtenstein
Status: En vigur
Scrittira da patent: Concedì
Annunzià: 30-03-2021
Publitgà: 08-02-2023
Concedì: 10-09-2025
La protecziun finescha il pli tard: 29-03-2041
Proxima taxa annuala scadenta: 31-03-2027
Classas IPC: C12N 15/11 (2006.01)
C12N 15/10 (2006.01)
C12N 9/22 (2006.01)
C12N 15/63 (2006.01)
C12N 9/78 (2006.01)
Prioritad: US 202063003159 P 31.03.2020
US 202063116149 P 19.11.2020
Dumonda PCT: PCT/US2021/024945 30.03.2021
Publicaziun PCT: WO2021/202568 07.10.2021
Lingua da l’annunzia: englais
Funtauna: Swissreg

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

22-07-2026
Midada
Published in Swissreg on 22.07.2026
10-04-2026
Adressa dal possessur midada
Owner
Metagenomi Therapeutics, Inc., 1545 Park Avenue, Emeryville, CA 94608, USA → Metagenomi Therapeutics, Inc., 5959 Horton St, 7th Floor, Emeryville, California 94608, USA
Published in Swissreg on 10.04.2026
01-04-2026
Next annual fee due on
Next annual fee due on
31.03.2026 → 31.03.2027
Published in Swissreg on 01.04.2026
06-03-2026
Adressa dal possessur midada
Owner
Metagenomi, Inc., 1545 Park Avenue, Emeryville, CA 94608, USA → Metagenomi Therapeutics, Inc., 1545 Park Avenue, Emeryville, CA 94608, USA
Published in Swissreg on 06.03.2026
19-09-2025
Represchentant inscrit
Representative
MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 19.09.2025
10-09-2025
Concedì
Specification status
Non-published patent application → Granted patent
Status of protective title
Initiated → Active
Published in Swissreg on 10.09.2025

5959 Horton St 7th Floor, Emeryville, California 94608, US

122, rue de Genève, CP 61, 1226 Thônex